Allergies News and Research

Latest Allergies News and Research

IDIBELL signs agreement with Histocell to use patent for acute pulmonary diseases with stem cells

The Bellvitge Biomedical Research Institute has signed a licensing agreement with the Spanish biotech company Histocell to make use of a patent for the treatment of acute pulmonary diseases with mesenchymal stem cells.

28 Mar 2013

Review article shows sublingual immunotherapy may be useful for allergic rhinitis, asthma

In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA.

27 Mar 2013

Oral drops are good for treating symptoms of allergies, allergic asthma in some people: Review

A scientific review of 63 published studies affirms that putting small amounts of purified grasses, ragweed, dust mites, pollen and mold, in liquid drops under the tongue is a safe and effective alternative to weekly injections of those allergens or the use of other medications, in treating symptoms of allergies and allergic asthma in some people.

27 Mar 2013

BioCryst starts BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

BioCryst Pharmaceuticals, Inc. announced the initiation of a Phase 1 clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of orally-administered BCX4161 in healthy volunteers.

25 Mar 2013

Scientists identify potential treatment for idiopathic pulmonary fibrosis

Investigators at the University of Alabama at Birmingham (UAB) have unlocked another piece of the puzzle surrounding idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments.

25 Mar 2013

Financial Times special report focuses on tuberculosis

The Financial Times has published a special report, titled "Combating Tuberculosis 2013," as World TB Day on March 24 approaches.

25 Mar 2013

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

The U.S. Food and Drug Administration announced today that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) to treat patients showing signs of botulism following documented or suspected exposure to botulinum neurotoxin.

25 Mar 2013

New class of anti-malarial compounds discovered

A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.

21 Mar 2013

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use.

20 Mar 2013

Scientists to engineer anti-allergy genetically modified apples

Scientists are trying to engineer apples so that the most widely consumed fruit in Europe no longer triggers allergic reactions.

20 Mar 2013

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.

19 Mar 2013

Passengers engaged in eight mitigating factors less likely to report allergic reaction, researchers find

Few situations can provoke more anxiety for people with peanut or tree-nut allergies than having an allergic reaction while flying on an airplane and being unable to get help.

16 Mar 2013

Cardiohelp assists heart by pumping blood to oxygenator in seriously ill patients

A viral infection was causing life-threatening heart failure in Loyola University Medical Center patient Michelle Rivera.

14 Mar 2013

Research finding aids efforts toward cytomegalovirus vaccine

A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero development, 1 in 750 children are born with or develop permanent disabilities such as hearing loss or brain damage.

14 Mar 2013

Gottlieb Allergy Count to officially begin on Mar. 18

The Gottlieb Allergy Count, reported by Joseph Leija, MD, will officially begin Monday, March 18, weeks earlier than the usual April 1 start date. For the past week, Dr.Leija has been monitoring the air daily in preparation.

12 Mar 2013

New rapid laboratory test successful in identifying GBS colonization in pregnant women

A more rapid laboratory test for pregnant women to detect potentially deadly Group B strep (GBS) has been successful at identifying GBS colonization in six and a half hours, according to the results of a study from The University of Texas Health Science Center at Houston (UTHealth).

11 Mar 2013

Urinary bisphenol A levels linked to asthma risk in children

Results from a US study suggest that urinary levels of the chemical bisphenol A are positively associated with wheeze and asthma risk in young children.

8 Mar 2013

Forceps delivery ‘does not increase atopy risk’

Results from a population-based cohort study suggest that forceps-assisted birth is associated with an increased risk for asthma, but not allergic sensitization, in later childhood.

5 Mar 2013

Discovery provides clues for potentially eliminating HIV infection in children

A two-year-old child born with HIV infection and treated with antiretroviral drugs beginning in the first days of life no longer has detectable levels of virus using conventional testing despite not taking HIV medication for 10 months, according to findings presented today at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

5 Mar 2013

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa.

5 Mar 2013

Allergies News and Research

Latest Allergies News and Research

IDIBELL signs agreement with Histocell to use patent for acute pulmonary diseases with stem cells

Review article shows sublingual immunotherapy may be useful for allergic rhinitis, asthma

Oral drops are good for treating symptoms of allergies, allergic asthma in some people: Review

BioCryst starts BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

Scientists identify potential treatment for idiopathic pulmonary fibrosis

Financial Times special report focuses on tuberculosis

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

New class of anti-malarial compounds discovered

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

Scientists to engineer anti-allergy genetically modified apples

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

Passengers engaged in eight mitigating factors less likely to report allergic reaction, researchers find

Cardiohelp assists heart by pumping blood to oxygenator in seriously ill patients

Research finding aids efforts toward cytomegalovirus vaccine

Gottlieb Allergy Count to officially begin on Mar. 18

New rapid laboratory test successful in identifying GBS colonization in pregnant women

Urinary bisphenol A levels linked to asthma risk in children

Forceps delivery ‘does not increase atopy risk’

Discovery provides clues for potentially eliminating HIV infection in children

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in